Navigation Links
Chem Rx Surpasses 65,000 Residents Served
Date:2/7/2008

- Exhibits Growth In All Existing Markets -

LONG BEACH, N.Y., Feb. 7 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: PMQC, PMQCU, PMQCW), the third largest long-term care pharmacy, today announced that it has surpassed 65,000 beds served. The Company experienced growth across all four of its institutional pharmacies, which serve a variety of long-term care facilities in the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania.

"The continued organic growth coupled with consistent revenue growth at all of our pharmacies demonstrates the success of our strategy to increase our market share and revenue in our existing regions," said Steven Silva, President and COO of Chem Rx. "We are pleased with the success that we have seen thus far in terms of creating growth and are also pleased with initial results from a recent SG&A review. We expect to continue these trends in our soon to be opened Deerfield Beach, FL pharmacy."

About Chem Rx

Founded more than 40 years ago, Chem Rx is a major, long-term care pharmacy serving the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Chem Rx provides to more than 65,000 residents prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Chem Rx Corporation. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's manag
'/>"/>

SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ZONARE Surpasses 1000th Worldwide z.one Ultrasound System Shipment
2. Left in the Dark and Facing Thousands in Rent Increases, Elderly Atria Senior Living Residents Protest; Call for Improvements
3. Colorado Residents and Visitors to Investigate Health in a Whole New Way
4. Rural Residents Get Fewer Organ Transplants: Study
5. Highmark to Present States Newest Residents with Healthcare Gift Cards
6. Long Term Care Pharmacy Alliance Expands Membership; Members Now Serve Most of the Nations Nursing Home Residents
7. Overwhelming Majority of Michigan Residents Favors Individual Health Insurance Market Reforms Supported by Blue Cross Blue Shield of Michigan
8. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
9. Report to Detail How Manor Care Buyout by The Carlyle Group Could Hamper Care for Florida Nursing Home Residents
10. PA Residents Losing Employer Coverage at Rate Second Only to CA
11. WellPoint Provides Support and Resources to Most Vulnerable California Residents
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 1ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 2ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 3Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2